Literature DB >> 29570207

Silencing of c-Ski augments TGF-b1-induced epithelial-mesenchymal transition in cardiomyocyte H9C2 cells.

Jia Ling1, Zhenrong Cai1, Wei Jin2, Xiaohua Zhuang1, Lihong Kan1, Fei Wang1, Xiaolei Ye3.   

Abstract

BACKGROUND: The shRNA lentiviral vector was constructed to silence c-Ski expression in cardiac mus- cle cells, with the aim of exploring the role of c-Ski in transforming growth factor b1 (TGF-b1)-induced epithelial-mesenchymal transitions (EMT) in H9C2 cells.
METHODS: Real-time polymerase chain reaction (RT-PCR) and western blot were used to detect c-Ski ex- pression at protein and messenger ribonucleic acid (mRNA) levels in 5 different cell lines. Then, lentiviral vector was constructed to silence or overexpress c-Ski in H9C2 cells. MTT and/or soft agar assay and tran- swell assay were used to detect cell proliferation and migration, respectively. The expression levels of c-Ski under different concentrations of TGF-b1 stimulation were detected by RT-qPCR and immunocytochemi- cal analysis. In the presence or absence of TGF-b1 stimulation, the proteins' expression levels of a-SMA, FN and E-cadherin, which are closely correlated with the process of EMT, were measured by western blot after c-Ski silencing or overexpression. Meanwhile, the effect of c-Ski on Samd3 phosphorylation with TGF-b1 stimulation was investigated.
RESULTS: There is a high expression of c-Ski at protein and mRNA levels in H9C2 cell line, which first demonstrated the presence of c-Ski expression in H9C2 cells. Overexpression of c-Ski significantly increased H9C2 cell proliferation. The ability of c-Ski gene silencing to suppress cell proliferation was gradually enhanced, and inhibition efficiency was the highest after 6 to 7 d of transfection. Moreover, H9C2 cells with c-Ski knockdown gained significantly aggressive invasive potential when compared with the control group. TGF-b1 stimulation could dose-independently reduce c-Ski expression in H9C2 cells and lead to obvious down-regulated expression of E-cadherin. Interestingly, c-Ski could restore E-cadherin expression while suppressing a-SMA and/or FN expression stimulated by TGF-b1. How- ever, shRNA-induced c-Ski knockdown aggravated only the TGF-b1-induced EMT. Moreover, c-Ski- -shRNA also promoted the phosphorylation of Samd3 induced by TGF-b1.
CONCLUSIONS: c-Ski expression in cardiac muscle cells could be down-regulated by TGF-b1. Silencing of c-Ski gene was accompanied by down-regulation of E-cadherin, up-regulation of a-SMA and/or FN and Smad3 phosphorylation induced by TGF-b1, promoting EMT process. Therefore, c-Ski may be closely associated with TGF-b1-induced EMT and play an important role in cardiac fibrosis develop- ment and progression.

Entities:  

Keywords:  TGF-b1-induced epithelial-mesenchymal transition; c-Ski; cardiac muscle cells; migration; proliferation

Mesh:

Substances:

Year:  2018        PMID: 29570207      PMCID: PMC8086681          DOI: 10.5603/CJ.a2018.0009

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  31 in total

Review 1.  Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension.

Authors:  Enrique Arciniegas; Maria G Frid; Ivor S Douglas; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-03-23       Impact factor: 5.464

2.  SnoN as a key regulator of the high glucose-induced epithelial-mesenchymal transition in cells of the proximal tubule.

Authors:  Ruixia Liu; Yuanyuan Wang; Ying Xiao; Mingjun Shi; Guozhong Zhang; Bing Guo
Journal:  Kidney Blood Press Res       Date:  2012-07-14       Impact factor: 2.687

Review 3.  TGF-β signaling in fibrosis.

Authors:  Anna Biernacka; Marcin Dobaczewski; Nikolaos G Frangogiannis
Journal:  Growth Factors       Date:  2011-07-11       Impact factor: 2.511

4.  Regulation of RANKL-induced osteoclastogenesis by TGF-β through molecular interaction between Smad3 and Traf6.

Authors:  Tetsuro Yasui; Yuho Kadono; Masaki Nakamura; Yasushi Oshima; Takumi Matsumoto; Hironari Masuda; Jun Hirose; Yasunori Omata; Hisataka Yasuda; Takeshi Imamura; Kozo Nakamura; Sakae Tanaka
Journal:  J Bone Miner Res       Date:  2011-07       Impact factor: 6.741

5.  c-Ski, Smurf2, and Arkadia as regulators of TGF-beta signaling: new targets for managing myofibroblast function and cardiac fibrosis.

Authors:  Ryan H Cunnington; Mansoreh Nazari; Ian M C Dixon
Journal:  Can J Physiol Pharmacol       Date:  2009-10       Impact factor: 2.273

Review 6.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

7.  Isolation of human cDNA clones of ski and the ski-related gene, sno.

Authors:  N Nomura; S Sasamoto; S Ishii; T Date; M Matsui; R Ishizaki
Journal:  Nucleic Acids Res       Date:  1989-07-25       Impact factor: 16.971

8.  Unique sequence, ski, in Sloan-Kettering avian retroviruses with properties of a new cell-derived oncogene.

Authors:  Y Li; C M Turck; J K Teumer; E Stavnezer
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

Review 9.  E-cadherin roles in animal biology: A perspective on thyroid hormone-influence.

Authors:  María Fernanda Izaguirre; Victor Hugo Casco
Journal:  Cell Commun Signal       Date:  2016-11-04       Impact factor: 5.712

10.  TGF-β1/Smad3 Signaling Pathway Suppresses Cell Apoptosis in Cerebral Ischemic Stroke Rats.

Authors:  Haiping Zhu; Qunfeng Gui; Xiaobo Hui; Xiaodong Wang; Jian Jiang; Lianshu Ding; Xiaoyang Sun; Yanping Wang; Huaqun Chen
Journal:  Med Sci Monit       Date:  2017-01-22
View more
  1 in total

1.  The Anti-fibrosis drug Pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-β.

Authors:  Gang Wang; Xiaowan Zhou; Zengli Guo; Nan Huang; Juan Li; Yanfang Lv; Lulu Han; Wei Zheng; Dandan Xu; Dafei Chai; Huizhong Li; Liantao Li; Junnian Zheng
Journal:  Cancer Biol Ther       Date:  2022-12-31       Impact factor: 4.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.